Patent · US Active

Substituted 2,3-dihydroimidazo[1,2-C]quinazoline salts

US9636344B2 · kind B2 · utility

10Cited by

8References

4Claims

0Family size

Assignee

Bayer Intellectual Property GmbH · DE

Inventors

Jan-Georg Peters · Solingen, DE
Hans-Christian Militzer · Odenthal, DE
Hartwig Muller · Velbert, DE

Key dates

Filing date	Jan 7, 2016
Grant date	May 2, 2017
Priority date	—
Expiry date	Jan 7, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates or a tautomer, solvate or hydrate thereof; and to its use for the treatment of non-Hodgkin's lymphoma.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.